publication venue for
- Real-world comparison of effectiveness between ustekinumab and a second-line anti-TNF agent in patients with symptomatic stricturing Crohn's disease failing to respond to a first-line anti-TNF agent: the USTEKNOSIS study.. -. 2025
- Risk of malnutrition increases in the year prior to surgery among patients with inflammatory bowel disease.. -. 2025
- Mirtazapine for gastrointestinal and neuropsychological symptoms in older adults with irritable bowel syndrome.. -. 2024
- Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease.. -. 2023